Lower riskDrug recall · FDA · Published June 28, 2018
Lupin Somerset Nitrofurantoin Oral Suspension Recall: Subpotent Drug Risk
Lupin Somerset recalls 230mL Nitrofurantoin Oral Suspension due to subpotent drug and failed content uniformity. This may not provide effective treatment for urinary tract infections. Consumers should contact the manufacturer for details.
“Lupin Somerset Nitrofurantoin Oral Suspension Recall: Subpotent Drug Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/40392-lupin-somerset-nitrofurantoin-oral-suspension-recall-subpotent-drug-risk. Based on FDA recall #D-0927-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0927-2018%22&limit=1).
The FDA announced on June 28, 2018, that Lupin Somerset is recalling Nitrofurantoin Oral Suspension USP due to subpotent drug and failed content uniformity hazards. Owners should contact the company for a refund.
How to tell if you have it
Brand: Lupin Somerset
Product: Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle
UPC: 00343386450114 (also listed as 343386-450-11)
Lot codes: S700065 (Exp. 02/2019), 700619 (Exp. 08/2019)
Units affected: 3,456 cartons
The hazard
The recall cites subpotent drug and failed content uniformity as the primary hazards. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Lupin Somerset has 8 other recalls on record since May 24, 2018. Other recent recalls of similar products include Lupin Somerset Morphine Sulfate Tablets Recall (April 10, 2019), Lupin Recalls Gavilyte-N Packets Due to Labeling Error (March 19, 2019), and Lupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities (Jan. 15, 2019). Additional recent recalls include Somerset Therapeutics Cisatracurium Besylate Injection Recall (Nov. 26, 2025), Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026), and Lupin Ganirelix Acetate Injection Recall (Nov. 13, 2025).
How to tell if you have this one
Check for the 230mL bottle labeled Nitrofurantoin Oral Suspension USP, 25mg/5mL, Rx Only. The product was manufactured by Novel Laboratories, Inc. and distributed by Lupin Pharmaceuticals, Inc.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0927-2018 (June 28, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0927-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.